May& Baker Nigeria Plc, a pharmaceutical manufacturer has introduced Malact, a new antimalarial medicine that promises to revolutionize malaria disease treatment in the country. The new drug, named Malact is a Dihydroarteminsin-piperaquine combination-based formulation which ensures fast reli
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp